Vermillion - Stock Price History | VRML

Historical daily share price chart and data for Vermillion since 2020 adjusted for splits. The latest closing stock price for Vermillion as of June 03, 2020 is 3.75.
  • The all-time high Vermillion stock closing price was 357.50 on November 07, 2000.
  • The Vermillion 52-week high stock price is 5.61, which is 49.6% above the current share price.
  • The Vermillion 52-week low stock price is 0.35, which is 90.7% below the current share price.
  • The average Vermillion stock price for the last 52 weeks is 0.94.
Vermillion Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.8284 0.3390 1.4400 0.3390 0.8100 170.00%
2018 0.9447 1.8000 1.8700 0.2900 0.3000 -84.46%
2017 1.6835 1.1000 2.6200 1.0900 1.9300 103.16%
2016 1.2973 1.7800 1.7899 0.8924 0.9500 -47.22%
2015 1.9465 1.9500 2.2700 1.6500 1.8000 -9.55%
2014 2.3778 2.5500 3.4000 1.2100 1.9900 -15.68%
2013 2.1501 1.3700 4.0400 1.0600 2.3600 78.79%
2012 1.7308 1.4500 3.0000 1.1800 1.3200 12.82%
2011 3.7975 6.8900 8.4400 1.0400 1.1700 -84.44%
2010 14.6295 25.8500 33.8100 4.7900 7.5200 -72.60%
2009 5.2285 0.3500 27.9900 0.0100 27.4500 10066.67%
2008 2.4174 7.5000 8.0000 0.2500 0.2700 -96.67%
2007 10.8610 10.1000 19.3000 6.5000 8.1000 -8.99%
2006 13.1625 11.3000 21.7000 8.4000 8.9000 -24.58%
2005 20.8468 41.3000 41.3000 8.6000 11.8000 -72.56%
2004 59.8119 84.1000 110.2000 26.9000 43.0000 -62.38%
2003 83.2639 34.2000 138.0000 32.9000 114.3000 231.30%
2002 44.6452 78.9000 78.9000 26.3000 34.5000 -56.88%
2001 56.1141 132.5000 132.5000 28.0000 80.0000 -39.62%
2000 238.4524 356.9000 357.5000 110.0000 132.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.375B $0.005B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $138.268B 28.08
Intuitive Surgical (ISRG) United States $67.616B 49.94
Edwards Lifesciences (EW) United States $46.369B 38.97
DexCom (DXCM) United States $34.699B 161.96
ALCON INC (ALC) Switzerland $30.893B 34.58
IDEXX Laboratories (IDXX) United States $26.880B 63.30
Fresenius Medical Care AG KGaA (FMS) Germany $25.853B 17.61
Olympus (OCPNY) Japan $24.515B 49.86
Teleflex (TFX) United States $16.954B 31.40
Sysmex ADR (SSMXY) Japan $16.521B 46.56
STERIS (STE) Ireland $13.964B 29.16
SONOVA HOLDING (SONVY) Switzerland $13.916B 0.00
Hologic (HOLX) United States $13.600B 21.41
Masimo (MASI) United States $12.695B 69.00
Varian Medical Systems (VAR) United States $11.279B 27.36
SARTORIUS AG (SARTF) Germany $10.734B 92.28
ABIOMED (ABMD) United States $10.370B 55.72
Penumbra (PEN) United States $6.183B 238.23
Globus Medical (GMED) United States $5.364B 33.94
Tandem Diabetes Care (TNDM) United States $4.949B 0.00
Integra LifeSciences Holdings (IART) United States $4.508B 20.67
Nevro (NVRO) United States $4.390B 0.00
Elekta AB (EKTAY) Sweden $4.059B 31.25
Wright Medical Group (WMGI) Netherlands $3.818B 592.40
Nihon Kohden (NHNKY) Japan $2.912B 0.00
LivaNova (LIVN) United Kingdom $2.604B 19.63
Integer Holdings (ITGR) United States $2.602B 16.08
Cantel Medical (CMD) United States $1.841B 17.72
Glaukos (GKOS) United States $1.823B 0.00
OPKO Health (OPK) United States $1.621B 0.00
Luminex (LMNX) United States $1.426B 0.00
ShockWave Medical (SWAV) United States $1.419B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.371B 26.57
Veracyte (VCYT) United States $1.302B 0.00
Silk Road Medical (SILK) United States $1.225B 0.00
Mesa Laboratories (MLAB) United States $1.095B 57.94
Tactile Systems Technology (TCMD) United States $0.935B 118.51
Inogen (INGN) United States $0.856B 51.10
CryoLife (CRY) United States $0.852B 118.84
OrthoPediatrics (KIDS) United States $0.837B 0.00
Natus Medical (NTUS) United States $0.740B 18.25
ORTHOFIX MEDICAL INC (OFIX) United States $0.664B 26.80
Quotient (QTNT) Switzerland $0.634B 0.00
GenMark Diagnostics (GNMK) United States $0.593B 0.00
Pacific Biosciences Of California (PACB) United States $0.567B 0.00
Si-Bone (SIBN) United States $0.522B 0.00
Accelerate Diagnostics (AXDX) United States $0.456B 0.00
AxoGen (AXGN) United States $0.392B 0.00
AngioDynamics (ANGO) United States $0.380B 25.23
Intersect ENT (XENT) United States $0.374B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.336B 0.00
SeaSpine Holdings (SPNE) United States $0.307B 0.00
Fluidigm (FLDM) United States $0.307B 0.00
Stereotaxis (STXS) United States $0.301B 0.00
Alphatec Holdings (ATEC) United States $0.295B 0.00
TransMedics (TMDX) United States $0.289B 0.00
Semler Scientific (SMLR) United States $0.281B 31.20
ViewRay (VRAY) United States $0.276B 0.00
IRadimed (IRMD) United States $0.267B 28.77
RTI Surgical (RTIX) United States $0.210B 56.80
Sientra (SIEN) United States $0.189B 0.00
Accuray (ARAY) United States $0.186B 0.00
CRH Medical (CRHM) Canada $0.137B 96.00
Electromed (ELMD) United States $0.131B 33.65
T2 Biosystems (TTOO) United States $0.128B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
Restoration Robotics (VERO) Canada $0.094B 0.00
EDAP TMS S.A (EDAP) France $0.074B 36.36
ConforMIS (CFMS) United States $0.064B 0.00
MRI Interventions (CLPT) United States $0.063B 0.00
Bioanalytical Systems (BASI) United States $0.057B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.057B 0.00
Sensus Healthcare (SRTS) United States $0.050B 0.00
Neovasc (NVCN) Canada $0.038B 0.00
Apollo Endosurgery (APEN) United States $0.037B 0.00
Allied Healthcare Products (AHPI) United States $0.035B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.034B 0.00
Neuronetics (STIM) United States $0.034B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Delcath Systems (DCTH) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
TransEnterix (TRXC) United States $0.021B 0.00
Helius Medical Technologies (HSDT) United States $0.020B 0.00
Xtant Medical Holdings (XTNT) United States $0.016B 0.00
Second Sight Medical Products (EYES) United States $0.016B 0.00
Sunshine Heart Inc (CHFS) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
American Shared Hospital Services (AMS) United States $0.012B 40.80
Avinger (AVGR) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.009B 0.00
OBALON THERPTCS (OBLN) United States $0.007B 0.00
Lianluo Smart (LLIT) China $0.007B 0.00
Ra Medical Systems (RMED) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.003B 0.00